Compare DXCM & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXCM | MTD |
|---|---|---|
| Founded | 1999 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 28.5B |
| IPO Year | 2005 | 1997 |
| Metric | DXCM | MTD |
|---|---|---|
| Price | $67.51 | $1,419.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 12 |
| Target Price | $86.86 | ★ $1,423.33 |
| AVG Volume (30 Days) | ★ 4.7M | 134.4K |
| Earning Date | 02-12-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.75 | ★ 8.22 |
| EPS | 1.80 | ★ 40.11 |
| Revenue | ★ $4,515,900,000.00 | $3,941,791,000.00 |
| Revenue This Year | $17.38 | $4.30 |
| Revenue Next Year | $12.76 | $4.73 |
| P/E Ratio | $37.61 | ★ $35.41 |
| Revenue Growth | ★ 14.21 | 4.77 |
| 52 Week Low | $54.11 | $946.69 |
| 52 Week High | $93.25 | $1,525.17 |
| Indicator | DXCM | MTD |
|---|---|---|
| Relative Strength Index (RSI) | 59.98 | 52.51 |
| Support Level | $65.56 | $1,399.68 |
| Resistance Level | $67.95 | $1,420.26 |
| Average True Range (ATR) | 1.80 | 27.21 |
| MACD | 0.08 | 0.42 |
| Stochastic Oscillator | 61.35 | 90.55 |
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.